Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Assets (2020 - 2023)

Historic Assets for Candel Therapeutics (CADL) over the last 4 years, with Q3 2023 value amounting to $50.1 million.

  • Candel Therapeutics' Assets fell 4110.96% to $50.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $50.1 million, marking a year-over-year decrease of 4110.96%. This contributed to the annual value of $77.7 million for FY2022, which is 1290.73% down from last year.
  • As of Q3 2023, Candel Therapeutics' Assets stood at $50.1 million, which was down 4110.96% from $58.7 million recorded in Q2 2023.
  • Candel Therapeutics' Assets' 5-year high stood at $101.6 million during Q1 2022, with a 5-year trough of $30.7 million in Q2 2021.
  • Over the past 4 years, Candel Therapeutics' median Assets value was $77.7 million (recorded in 2022), while the average stood at $71.6 million.
  • As far as peak fluctuations go, Candel Therapeutics' Assets soared by 20347.71% in 2022, and later tumbled by 4110.96% in 2023.
  • Over the past 4 years, Candel Therapeutics' Assets (Quarter) stood at $38.3 million in 2020, then soared by 133.02% to $89.2 million in 2021, then dropped by 12.91% to $77.7 million in 2022, then tumbled by 35.56% to $50.1 million in 2023.
  • Its Assets was $50.1 million in Q3 2023, compared to $58.7 million in Q2 2023 and $67.2 million in Q1 2023.